Zydus

An additional advantage with the Zydus Cadila vaccine is the fact that it is needle-free and thereby reduces the body pain and other side effects that are experienced with other…

By ANI NEW DELHI: India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its…

If regulators consent, ZyCoV-D could become the second home-grown shot, after Bharat Biotech's Covaxin; and fourth to get a DCGI nod for use against the viral infection in India after…

India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that…

The Phase 3 trials on more than 28,000 volunteers across 50 clinical sites, have shown an efficacy rate of 66.6%. That is lower than the efficacy levels of vaccines from Moderna and…

ZyCov-D Coronavirus Vaccine is the first needle free three dose vaccine. (Representative Image)What is ZyCov-D Needle-Free Covid-19 Vaccine: India’s first Plasmid DNA Covid-19 vaccine,…

New Delhi, June 27 Zydus Cadila Covid-19 vaccine for children above 12 years is expected to be available by August as its trials are likely…